Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Symbol</td><td class="align_center">Coef</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">CYP1B1</td><td class="align_center">0.11119677191537</td></tr><tr><td class="align_left">ACOT13</td><td class="align_center">−0.371344139411004</td></tr><tr><td class="align_left">NUDT19</td><td class="align_center">−0.461089925531869</td></tr><tr><td class="align_left">SCD</td><td class="align_center">0.199677207803535</td></tr><tr><td class="align_left">IL4I1</td><td class="align_center">−0.302776856487651</td></tr><tr><td class="align_left">DECR1</td><td class="align_center">−0.475644491902455</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Signature genes and their coefficient.</div>

Journal of Oncology

tab2

Table 2

Table 2: Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy 